Mrv1909 01102015282D 15 15 0 0 0 0 999 V2000 1.7861 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0716 0.4125 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.0716 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 -0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 2 1 0 0 0 0 4 2 1 0 0 0 0 4 5 1 1 0 0 0 6 4 1 0 0 0 0 7 6 1 0 0 0 0 8 7 2 0 0 0 0 12 7 1 0 0 0 0 9 12 1 0 0 0 0 14 8 1 0 0 0 0 10 9 2 0 0 0 0 14 10 1 0 0 0 0 11 10 1 0 0 0 0 12 13 2 0 0 0 0 14 15 2 0 0 0 0 M END > DB04334 > drugbank > N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O > InChI=1S/C9H9NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,13H,1,10H2,(H,14,15)/t5-/m0/s1 > AGMJSPIGDFKRRO-YFKPBYRVSA-N > C9H9NO5 > 211.1715 > 211.048072403 > 6 > 24 > -0.947310601485089 > 19.03316276798293 > 1 > 3 > 0 > 0 > (2S)-2-amino-3-(4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl)propanoic acid > -2.02 > -2.7784074538421977 > -2.02 > 0 > -1 > 1 > -1 > 5.8378544946733495 > 1.7302422779675064 > 9.034904358677661 > 117.69000000000003 > 51.370400000000004 > 3 > 1 > 2.01e+00 g/l > (2S)-2-[(4-{2-[(6S)-2-amino-4-oxo-1H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-6-yl]ethyl}phenyl)formamido]pentanedioic acid > 0 > DB04334 > EXPT03094 > experimental > 6-hydroxydopa quinone > (S)-α-amino-4-hydroxy-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid; 6-Hydroxyphenylalanine-3,4-dione; L-topaquinone; Topa quinone; Topaquinone $$$$